Evaluation of β-catenin expression in muscle-invasive urothelial bladder carcinoma

Urothelial Bladder ◽

Faculty Opinions recommendation of Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734259396.793578102 ◽

2020 ◽

Author(s):

Matthew Milowsky

Keyword(s):

Neoadjuvant Therapy ◽

Radical Cystectomy ◽

Phase Ii ◽

Bladder Carcinoma ◽

Phase Ii Study ◽

Open Label ◽

Urothelial Bladder ◽

PURE01: An open label, single-arm, phase 2 study of the anti-programmed death (PD)-1 monoclonal antibody (moAb) pembrolizumab for neoadjuvant therapy of muscle-invasive urothelial bladder carcinoma (miUBC)

Annals of Oncology ◽

10.1093/annonc/mdw373.74 ◽

2016 ◽

Vol 27 ◽

pp. vi294

Author(s):

A. Necchi ◽

L. Mariani ◽

A. Anichini ◽

P. Giannatempo ◽

D. Raggi ◽

...

Keyword(s):

Monoclonal Antibody ◽

Neoadjuvant Therapy ◽

Bladder Carcinoma ◽

Phase 2 ◽

Open Label ◽

Programmed Death ◽

Phase 2 Study ◽

Urothelial Bladder ◽

Early-Invasive Urothelial Bladder Carcinoma and Instillation Treatment of Non-muscle-Invasive Bladder Cancer

Urologic Oncology ◽

10.1007/978-3-319-42623-5_20 ◽

2019 ◽

pp. 327-335

Author(s):

Wolfgang Otto ◽

Maximilian Burger ◽

Johannes Breyer

Keyword(s):

Bladder Cancer ◽

Bladder Carcinoma ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Urothelial Bladder ◽

Early surgical safety outcomes from PURE-01: Secondary analysis from a phase 2 open-label study of neoadjuvant pembrolizumab (pembro) before radical cystectomy for muscle-invasive urothelial bladder carcinoma (MIUC)

European Urology Supplements ◽

10.1016/s1569-9056(18)31211-9 ◽

2018 ◽

Vol 17 (2) ◽

pp. e523-e524 ◽

Cited By ~ 1

Author(s):

A. Briganti ◽

A. Necchi ◽

D. Raggi ◽

P. Giannatempo ◽

M. Bianchi ◽

...

Keyword(s):

Bladder Carcinoma ◽

Secondary Analysis ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Surgical Safety ◽

Urothelial Bladder ◽

A pilot pre-surgical study evaluating anti-PD-L1 durvalumab (durva) plus anti-CTLA-4 tremelimumab (treme) in patients with muscle-Invasive, high-risk urothelial bladder carcinoma who are ineligible for cisplatin-based neoadjuvant chemotherapy.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e16524 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e16524-e16524 ◽

Cited By ~ 1

Author(s):

Jianjun Gao ◽

Arlene O. Siefker-Radtke ◽

Neema Navai ◽

Matthew T. Campbell ◽

Rebecca Slack ◽

...

Keyword(s):

High Risk ◽

Neoadjuvant Chemotherapy ◽

Bladder Carcinoma ◽

Urothelial Bladder ◽

Status of Her2 over expression in muscle invasive urothelial bladder carcinoma: Report of 21 cases

Urology Annals ◽

10.4103/0974-7796.127033 ◽

2014 ◽

Vol 6 (1) ◽

pp. 63 ◽

Cited By ~ 3

Author(s):

Nesrine Mejri ◽

Rym Sellami ◽

Charfi Lamia ◽

Doghri Raoudha ◽

NazihaB Hmida ◽

...

Keyword(s):

Bladder Carcinoma ◽

Over Expression ◽

Urothelial Bladder ◽

Abstract CT003: Preoperative pembrolizumab (pembro) before radical cystectomy (RC) for muscle-invasive urothelial bladder carcinoma (MIUC): Interim clinical and biomarker findings from the phase II PURE-01 study

10.1158/1538-7445.am2018-ct003 ◽

2018 ◽

Cited By ~ 1

Author(s):

Andrea Necchi ◽

Alberto Briganti ◽

Marco Bianchi ◽

Daniele Raggi ◽

Patrizia Giannatempo ◽

...

Keyword(s):

Radical Cystectomy ◽

Phase Ii ◽

Bladder Carcinoma ◽

Urothelial Bladder ◽

PD23-08 POTENTIAL BLOOD-BASED TUMOR MARKERS FOR NON-MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA.

The Journal of Urology ◽

10.1016/j.juro.2015.02.1424 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Daher Chade ◽

Leopoldo Ribeiro-Filho ◽

Mauricio Cordeiro ◽

Pedro Filipecki ◽

Claudio Murta ◽

...

Keyword(s):

Tumor Markers ◽

Bladder Carcinoma ◽

Urothelial Bladder ◽

P026 Prognosis of primary and progressive muscle-invasive urothelial bladder carcinoma – Is there a difference?

European Urology Supplements ◽

10.1016/s1569-9056(13)60404-2 ◽

2012 ◽

Vol 11 (5) ◽

pp. 199

Author(s):

A. Ciudin ◽

M.G. Diaconu ◽

A. Molina ◽

J. Huguet ◽

L. Peri ◽

...

Keyword(s):

Bladder Carcinoma ◽

Urothelial Bladder ◽

Expression of Topoisomerase II Alpha, ki67, and p53 in Primary Non-Muscle-Invasive Urothelial Bladder Carcinoma

Journal of Immunoassay and Immunochemistry ◽

10.1080/15321819.2014.899254 ◽

2014 ◽

Vol 35 (4) ◽

pp. 358-367 ◽

Cited By ~ 5

Author(s):

Soumaya Ben Abdelkrim ◽

Soumaya Rammeh ◽

Sonia Ziadi ◽

Taghrid Tlili ◽

Mahdi Jaidane ◽

...

Keyword(s):

Bladder Carcinoma ◽

Topoisomerase Ii ◽

Topoisomerase Ii Alpha ◽

Urothelial Bladder ◽